Financials
Financial year 2024
WANDJI PHARMA INTERNATIONAL from Tournai, company number BE0555655986, closed financial year 2024 with a result of € 22,455 after tax. For that financial year WANDJI PHARMA INTERNATIONAL recorded a gross margin of € 30,451 and equity of € 89,841. Compared with financial year 2023, the result moved from € 19,533 to € 22,455. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2025.
€ 89,841
▲ 33% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 22,455
▲ 15% vs 2023
Profit after tax over the fiscal year.
€ 190,510
▲ € 189,912 vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € -53,759.
Debts at end 2024
€ 199,339
▲ € 175,925 vs 2023
€ 11,909 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.
€ 10,641
▼ 80% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 11
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 20,123 | € -913 | € 38,915 | € 30,451 | ▼ 22% |
| Profit after taxes | € 16,021 | € -4,548 | € 19,533 | € 22,455 | ▲ 15% |
| Equity | € -72,599 | € -77,147 | € 67,387 | € 89,841 | ▲ 33% |
| Total debts | € 216,841 | € 213,098 | € 97,955 | € 267,276 | ▲ 173% |
| Cash | € 37 | € 30 | € 597 | € 190,510 | ▲ € 189,912 |
| Retained profit | € -91,199 | € -95,747 | € -76,213 | € -53,759 | ▲ € 22,455 |
| Bank debt | € 51,738 | € 36,871 | € 23,414 | € 199,339 | ▲ € 175,925 |
| Balance sheet total | € 144,242 | € 135,951 | € 165,342 | € 357,118 | ▲ 116% |
Key figures of WANDJI PHARMA INTERNATIONAL, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to WANDJI PHARMA INTERNATIONAL?
What happened at WANDJI PHARMA INTERNATIONAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 22,455 (▲ 15% vs 2023). filed late Source: NBB ↗
- FABRICE WANDJI became a director. NBB
- New establishment in Tournai. KBO
- Start of the company according to the CBE. KBO
In short
From € 16,021 profit in 2021 to € 22,455 profit in 2024.
Best year ever: 2024, with € 22,455 profit.
A new publication or filing at WANDJI PHARMA INTERNATIONAL? We notify you, reason included.
Follow WANDJI PHARMA INTERNATIONALDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of REANESURG WANDJI comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
WANDJI PHARMA INTERNATIONALBehind WANDJI PHARMA INTERNATIONAL is FABRICE WANDJI. The shares are held by REANESURG WANDJI (87%).
Directors
According to the 2024 annual accounts
FABRICE WANDJI
Director
since 2024
Shareholders
87%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Chaussée de Frasnes(MEL) 502
7540 Tournai
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0555.655.986
- VAT number
- BE 0555.655.986
- Registered office
- Chaussée de Frasnes(MEL) 502, 7540 Tournai
- Names & denominations
- WANDJI PHARMA INTERNATIONAL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 July 2014
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Vervaardiging van geneesmiddelen
Detailhandel in farmaceutische producten